Skip to main content
Health Podcast Library

S3, E4: ReproNovo’s strategic trash-to-treasure bet on fertility and reproductive health - with CEO Jean Marie Duval

Raising Biotech · 32 min

Episode Description

In this episode, we dive into ReproNovo’s “trash to treasure” biotech story. Founded in Switzerland in 2021, the company is reimagining reproductive medicine, one of the most underserved areas in biotech, by reviving overlooked and discarded assets. Earlier this year, ReproNovo raised a $65M Series A from a syndicate of esteemed European investors to advance programs in male infertility, embryo implantation, and adenomyosis.

CEO Jean Marie Duval reflects on her unconventional path from patent attorney to biotech CEO, why she and her co-founders put their own capital on the line, and how they convinced investors to back them without fresh data. We also talk about the unique hurdles of drug development in fertility, the challenge of designing and powering clinical trials, and why the next two years will be pivotal for ReproNovo to prove its vision of revival and hopes for a successful exit.

Timestamps

  • 00:00 – Introduction

  • 02:00 – Jean Marie’s elevator pitch on ReproNovo

  • 03:00 – Pipeline overview: RPN-001 and RPN-002, from Novartis/Mereo and ObsEva

  • 06:00 – Jean Marie’s career journey: from biomedical engineer to patent attorney to pharma exec and biotech CEO

  • 07:30 – Founding story: bootstrapping, co-founders, and the first in-license

  • 10:00 – The 18-month grind: capital risk, grit, and courage

  • 12:00 – Bringing in M Ventures and building the Series A syndicate

  • 15:00 – Convincing investors in an under-served field

  • 19:00 – Asset history: male infertility data signals, IVF trial failures, and fresh strategies

  • 21:30 – Embryo implantation and adenomyosis: unmet need and opportunity

  • 22:00 – Clinical trial plans: Phase II timelines, endpoints, and design challenges

  • 26:30 – Safety vs efficacy: the importance of balancing risk in women’s health trials

  • 28:30 – Trial recruitment and patient motivation

  • 30:00 – Looking ahead: pivotal studies, Series B or big pharma exit

    For any comments, questions or feedback you can connect directly with ⁠⁠Surani Fernando⁠⁠ on LinkedIn or email: raisingbiotech@gmail.com

    Title music composed by: Yrii Semchyshyn (Coma Media)

Proudly Supported by

BetterHelpForvis MazarsAAOSCalendarPAmowPod

Patrons of Health Podcast Library

AAOS Now Podcast
OrthoInfo
AAOS Career Podcast
Achieving Health
Aging Like a Pro
Stronger After Stroke
Who the Health Cares? with Prof Michael Sparer

Supporting Shows

Beyond The Paper Gown Podcast
Coffee Break: Breaking the Cycle of Bullying in Healthcare, One Cup at a Time
Healthcare for Humans
Beyond Clinical Walls
HITea With Grace
Hopeful Hints
Coaching Healthcare Leaders
Thriving with Addiction with Dr. Jonathan Avery
Faces of Digital Health
HIT Like a Girl Pod: Empowering Women in Health IT
This Just In Radio Show
Nurse Rosa's INsights
Cuts and Consults
Impulse | Meeting Healthcare Pioneers
Speak Up For Your Health
On the Pulse Podcast

We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies